Prime Medicine Maintained at Buy with Unchanged $6 Price Target on Emerging Program Clarity and 2027 Catalysts
at www.tipranks.com (Mon, 17-Aug 3:25 PM)
Prime Medicine Secures Arbitration Win, Paving Way for PM647 Clinical Advances—Key Dates and Pipeline Focus Stand Out
Market Chameleon (Wed, 8-Jul 11:06 AM)
